The stock has a 36-month beta value of 1.78. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OMGA is 20.45M, and at present, short sellers hold a 31.11% of that float. On November 15, 2024, the average trading volume of OMGA was 241.55K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OMGA) stock’s latest price update
Omega Therapeutics Inc (NASDAQ: OMGA) has experienced a decline in its stock price by -16.40 compared to its previous closing price of 1.01. However, the company has seen a fall of -22.53% in its stock price over the last five trading days. zacks.com reported 2024-11-14 that Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.40 per share a year ago.
OMGA’s Market Performance
Omega Therapeutics Inc (OMGA) has experienced a -22.53% fall in stock performance for the past week, with a -18.81% drop in the past month, and a -45.87% drop in the past quarter. The volatility ratio for the week is 8.29%, and the volatility levels for the past 30 days are at 13.73% for OMGA. The simple moving average for the last 20 days is -27.78% for OMGA’s stock, with a simple moving average of -61.33% for the last 200 days.
Analysts’ Opinion of OMGA
Raymond James, on the other hand, stated in their research note that they expect to see OMGA reach a price target of $12. The rating they have provided for OMGA stocks is “Outperform” according to the report published on June 18th, 2024.
Jefferies gave a rating of “Buy” to OMGA, setting the target price at $15 in the report published on May 25th of the previous year.
OMGA Trading at -28.27% from the 50-Day Moving Average
After a stumble in the market that brought OMGA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.60% of loss for the given period.
Volatility was left at 13.73%, however, over the last 30 days, the volatility rate increased by 8.29%, as shares sank -21.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.43% lower at present.
During the last 5 trading sessions, OMGA fell by -23.26%, which changed the moving average for the period of 200-days by -74.80% in comparison to the 20-day moving average, which settled at $1.1688. In addition, Omega Therapeutics Inc saw -71.95% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for OMGA
Current profitability levels for the company are sitting at:
- -9.16 for the present operating margin
- -0.6 for the gross margin
The net margin for Omega Therapeutics Inc stands at -9.03. The total capital return value is set at -0.58. Equity return is now at value -129.15, with -39.72 for asset returns.
Based on Omega Therapeutics Inc (OMGA), the company’s capital structure generated 0.92 points at debt to capital in total, while cash flow to debt ratio is standing at -0.43.
Currently, EBITDA for the company is -93.49 million with net debt to EBITDA at -1.41. When we switch over and look at the enterprise to sales, we see a ratio of 17.73. The receivables turnover for the company is 16.66for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.19.
Conclusion
To sum up, Omega Therapeutics Inc (OMGA) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
